Info@ThinkPinkRocks.com

Neoadjuvant endocrine therapy ‘a reasonable option’ for ER-positive breast cancer

Endocrine therapy should be reconsidered as a potential option in the neoadjuvant setting for localised oestrogen receptor-positive breast cancer, say the authors of a meta-analysis.

Read More:
Neoadjuvant endocrine therapy ‘a reasonable option’ for ER-positive breast cancer

Share

Leave a Reply